Drug
Tamoxifen 20mg
Tamoxifen 20mg is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph phase_1
1
33%
Ph phase_2
1
33%
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
Phase 2Efficacy & side effects
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Not yet recruiting1
Recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 11 (50.0%)
Phase 21 (50.0%)
Trials by Status
not_yet_recruiting133%
recruiting133%
unknown133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_1
Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection
NCT06320990
not_yet_recruitingphase_2
Maintenance Hormonal Therapy and DLBCL
NCT06355401
unknown
Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia
NCT05800197
Clinical Trials (3)
Showing 3 of 3 trials
NCT06320990Phase 1
Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection
NCT06355401Phase 2
Maintenance Hormonal Therapy and DLBCL
NCT05800197
Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3